Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem?
Anakinra
COVID-19
Cardiac magnetic resonance
Intravenous immunoglobulin
Kawasaki disease
Methylprednisolone
Multisystem inflammatory syndrome in children (MIS-C)
SARS-CoV-2
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
received:
07
01
2024
accepted:
07
04
2024
medline:
4
5
2024
pubmed:
4
5
2024
entrez:
3
5
2024
Statut:
epublish
Résumé
Multisystem inflammatory syndrome in children (MIS-C) shows a significant overlap of symptoms with other hyper-inflammatory diseases such as Kawasaki disease (KD), but the real difference of the two conditions is still matter of debate. Coronary artery lesions (CAL) are the most relevant complication in KD. Nonetheless, CAL, myocarditis, pericarditis, arrhythmia are the main cardiovascular complications in MIS-C. A close clinical assessment is mandatory, both at the diagnosis and during the follow-up, by ECG and echocardiography. Cardiac magnetic resonance (MRI) adds important data to ultrasound findings. However, cardiac MRI studies in MIS-C are limited to a small number of cohorts. We enrolled 20 children (age:1-16 years; 11 F; 9 M) with cardiac involvement secondary to MIS-C, all evaluated by cardiac MRI. 8 children showed pathological cardiac MRI: 2 showed pericardial effusion; 2 showed myocardial oedema; 1 showed aortic insufficiency; 3 showed delayed enhancement (one for acute myocarditis with oedema; 2 for myocardial fibrosis). Delayed enhancement was reduced significantly 5.6-9 months after the first MRI evaluation. 25% of patients with pathological MRI had CAL associated with valvular insufficiency of 2 valves. 17% of patients with normal MRI had CAL, associated with valvular insufficiency of 1 valve in 1 patient. The correlations between haematological, clinical, cardiologic parameters, treatment, did not reach the statistical significance. 4 patients were treated with anakinra. Among those, 2 patients showed a normal cardiac MRI. Cardiac lesions resolved in all the patients during the follow-up. Some patients with pathological cardiac MRI could not underwent a control with MRI, for the low compliance. However, echocardiography and ECG, documented the resolution of the pathological data in these cases. A higher risk of CAL was documented in patients with an association of other cardiac lesions. Cardiac MRI is difficult to perform routinely; however, it is useful for evaluating the acute myocardial damage and the outcome of patients with MIS-C.
Sections du résumé
BACKGROUND
BACKGROUND
Multisystem inflammatory syndrome in children (MIS-C) shows a significant overlap of symptoms with other hyper-inflammatory diseases such as Kawasaki disease (KD), but the real difference of the two conditions is still matter of debate. Coronary artery lesions (CAL) are the most relevant complication in KD. Nonetheless, CAL, myocarditis, pericarditis, arrhythmia are the main cardiovascular complications in MIS-C. A close clinical assessment is mandatory, both at the diagnosis and during the follow-up, by ECG and echocardiography. Cardiac magnetic resonance (MRI) adds important data to ultrasound findings. However, cardiac MRI studies in MIS-C are limited to a small number of cohorts.
METHODS
METHODS
We enrolled 20 children (age:1-16 years; 11 F; 9 M) with cardiac involvement secondary to MIS-C, all evaluated by cardiac MRI.
RESULTS
RESULTS
8 children showed pathological cardiac MRI: 2 showed pericardial effusion; 2 showed myocardial oedema; 1 showed aortic insufficiency; 3 showed delayed enhancement (one for acute myocarditis with oedema; 2 for myocardial fibrosis). Delayed enhancement was reduced significantly 5.6-9 months after the first MRI evaluation. 25% of patients with pathological MRI had CAL associated with valvular insufficiency of 2 valves. 17% of patients with normal MRI had CAL, associated with valvular insufficiency of 1 valve in 1 patient. The correlations between haematological, clinical, cardiologic parameters, treatment, did not reach the statistical significance. 4 patients were treated with anakinra. Among those, 2 patients showed a normal cardiac MRI. Cardiac lesions resolved in all the patients during the follow-up. Some patients with pathological cardiac MRI could not underwent a control with MRI, for the low compliance. However, echocardiography and ECG, documented the resolution of the pathological data in these cases.
CONCLUSIONS
CONCLUSIONS
A higher risk of CAL was documented in patients with an association of other cardiac lesions. Cardiac MRI is difficult to perform routinely; however, it is useful for evaluating the acute myocardial damage and the outcome of patients with MIS-C.
Identifiants
pubmed: 38702753
doi: 10.1186/s13052-024-01658-1
pii: 10.1186/s13052-024-01658-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
91Informations de copyright
© 2024. The Author(s).
Références
Melgar M, Lee EH, Miller AD, Lim S, Brown CM, Yousaf AR, Zambrano LD, Belay ED, Godfred-Cato F, Abrams JY, Oster ME, Campbell AP, Council of state and territorial epidemiologists. Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 infection. United States. 2022;Recomm Rep(16):36520808. PMCID: PMC9762894.
Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, Cardinale F, Cattalini M, De Zorzi A, Dellepiane RM, Salice P, Secinaro A, Taddio A, Palma P, El Hachem M, Cortis E, Maggio MC, Corsello G, Villani A. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021;47(1):16. https://doi.org/10.1186/s13052-021-00962-4 . PMID: 33494789; PMCID: PMC7830049.
doi: 10.1186/s13052-021-00962-4
pubmed: 33494789
pmcid: 7830049
Maggio MC, Corsello G, Prinzi E, Cimaz R. Kawasaki disease in Sicily: clinical description and markers of disease severity. Ital J Pediatr. 2016;42(1):92. https://doi.org/10.1186/s13052-016-0306-z . PMID: 27806720; PMCID: PMC5094032.
doi: 10.1186/s13052-016-0306-z
pubmed: 27806720
pmcid: 5094032
Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D’Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A. Kawasaki disease: guidelines of the Italian society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44(1):102. https://doi.org/10.1186/s13052-018-0536-3 . PMID: 30157897; PMCID: PMC6116535.
doi: 10.1186/s13052-018-0536-3
pubmed: 30157897
pmcid: 6116535
Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D’Isanto L,j, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A. Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital J Pediatr. 2018;44(1):103. https://doi.org/10.1186/s13052-018-0529-2 . PMID: 30157893; PMCID: PMC6116479.
Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev. 2018;17(8):768–74. Epub 2018 Jun 6. PMID: 29885546.
doi: 10.1016/j.autrev.2018.01.024
pubmed: 29885546
Accomando S, Liotta A, Maggio MC, Cardella F, Corsello G. Infliximab administration effective in the treatment of refractory Kawasaki disease. Pediatr Allergy Immunol. 2010;21(7):1091-2. https://doi.org/10.1111/j.1399-3038.2010.01029.x . PMID: 20977502.
Maggio MC, Giordano S, Failla MC, Campione MG, Alaimo A, Corsello G. Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo. Ital J Pediatr. 2023;49(1):37. https://doi.org/10.1186/s13052-023-01416-9 . PMID: 36959663; PMCID: PMC10034232.
doi: 10.1186/s13052-023-01416-9
pubmed: 36959663
pmcid: 10034232
Sirico D, Basso A, Reffo E, Cavaliere A, Castaldi B, Sabatino J, Meneghel A, Martini G, Da Dalt L, Zulian F, Di Salvo G. Early echocardiographic and cardiac MRI findings in Multisystem Inflammatory Syndrome in Children. J Clin Med. 2021;10(15):3360. https://doi.org/10.3390/jcm10153360 . PMID: 34362141; PMCID: PMC8348478.
doi: 10.3390/jcm10153360
pubmed: 34362141
pmcid: 8348478
Arslan SY, Bal ZS, Bayraktaroglu S, Ozenen GG, Bilen NM, Levent E, Ay O, Ozkaya PY, Ozkinay F, Cicek C, Cinkooglu A, Aksu G, Ak G, Kurugol Z. Cardiac Assessment in Children with MIS-C: late magnetic resonance imaging features. Pediatr Cardiol. 2023;44(1):44–53. https://doi.org/10.1007/s00246-022-02977-y . Epub 2022 Aug 2. PMID: 35916926; PMCID: PMC9343565.
doi: 10.1007/s00246-022-02977-y
pubmed: 35916926
Karagözlü S, Ramoğlu MG, Bayram Ö, Bakhtiyarzada J, Aydın A, Yılmaz MM, Murt B, Özkan E, İnceli HB, Gurbanov A, Şükriye Y, Demir B, Özdemir H, Çiftçi E, Kendirli T, Uçar T, Fitoz ÖS, Tutar E. Cardiovascular manifestations and cardiac magnetic resonance follow-up of multisystem inflammatory syndrome in children (MIS-C). Cardiol Young. 2023:1–10. doi: 10.1017/S1047951123001348. Epub ahead of print. PMID: 37381829.
Scarduelli L, De Guillebon De Resnes JM, Ducreux D, Bernardor J, Afanetti M, Dupont A, Barthelemy S, Gondon E, Leporati J, Giovannini-Chami L, Moceri P. Cardiac manifestations of MIS-C: cardiac magnetic resonance and speckle-tracking data. Front Cardiovasc Med. 2023;10:1288176. https://doi.org/10.3389/fcvm.2023.1288176 . PMID: 38028482; PMCID: PMC10657844.
doi: 10.3389/fcvm.2023.1288176
pubmed: 38028482
pmcid: 10657844
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Kernan KF, Schulert GS, Seo P, Son MBF, Tremoulet AH, VanderPluym C, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74(4):e1–20. https://doi.org/10.1002/art.42062 . Epub 2022 Feb 3. PMID: 35118829; PMCID: PMC9011620.
doi: 10.1002/art.42062
pubmed: 35118829
pmcid: 9011620
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. May 2020. URL: https://www.who.int/publications/i/item/multisystem‐inflammatory‐syndrome‐in‐children‐and‐adolescents‐with‐covid‐19 .
Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. May 2020. URL: https://emergency.cdc.gov/han/2020/han00432.asp . American Accademy of Pediatrics: Multisystem Inflammatory Syndromein Children (MIS-C) Interim Guidance, last updated: 02/08/2023.
Zimmerman D, Shwayder M, Souza A, Su JA, Votava-Smith J, Wagner-Lees S, Kaneta K, Cheng A, Szmuszkovicz J. Cardiovascular Follow-up of Patients Treated for MIS-C. Pediatrics. 2023;152(6):e2023063002. https://doi.org/10.1542/peds.2023-063002 . PMID: 37964674.
Barris DM, Keelan J, Ahluwalia N, Jhaveri S, Cohen J, Stern K, Seiden HS, Glass L. Midterm outcomes and Cardiac Magnetic Resonance Imaging following Multisystem Inflammatory Syndrome in Children. J Pediatr. 2022;241:237–e2411. https://doi.org/10.1016/j.jpeds.2021.10.009 . Epub 2021 Oct 21. PMID: 34687695.
doi: 10.1016/j.jpeds.2021.10.009
pubmed: 34687695
Webster G, Patel AB, Carr MR, Rigsby CK, Rychlik K, Rowley AH, Robinson JD. Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study. J Cardiovasc Magn Reson. 2021;23(1):86. https://doi.org/10.1186/s12968-021-00786-5 . PMID: 34193197; PMCID: PMC8245157.
doi: 10.1186/s12968-021-00786-5
pubmed: 34193197
pmcid: 8245157
Giordano S, Failla MC, Li Cavoli MG, Romano D, Vanella V, Caruso C, Chillura I, Maggio MC. A 7-Year-old boy and a 14-Year-old girl initially diagnosed with toxic shock syndrome and tested positive for SARS-CoV-2 infection, supporting a diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C). Am J Case Rep. 2021;22:e931570. https://doi.org/10.12659/AJCR.931570 . PMID: 34635631; PMCID: PMC8522524.
doi: 10.12659/AJCR.931570
pubmed: 34635631
pmcid: 8522524
Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, Sota J, Dinarello CA. Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021;20(3):102763. Epub 2021 Jan 20. PMID: 33482337.
doi: 10.1016/j.autrev.2021.102763
pubmed: 33482337
Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A, Rheumatology Study Group of the Italian Pediatric Society. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021;19(1):29. https://doi.org/10.1186/s12969-021-00511-7 . PMID: 33726806; PMCID: PMC7962084.
doi: 10.1186/s12969-021-00511-7
pubmed: 33726806
pmcid: 7962084
Taddio A, Della Paolera S, Abbagnato L, Agrusti A, Badolato R, Biscaro F, Caorsi R, Consolaro A, Dellepiane RM, Fabi M, Floretta I, Gattorno M, Giangreco M, La Torre F, Maggio MC, Mambelli L, Mauro A, Mastrolia MV, Meneghel A, Montin D, Ricci F, Simonini G, Smarrazzo A, Sottile R, Stucchi S, Tardi M, Verdoni L, Zuccotti G, Zunica F, Ravelli A, Cattalini M. Italian Society of Pediatric Rheumatology (ReumaPed). Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity. Rheumatology (Oxford). 2024;63(2):366–375. https://doi.org/10.1093/rheumatology/kead381 . PMID: 37647645.
Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L. Anakinra Drug Retention Rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult Onset still Disease. Front Pharmacol. 2019;10:918. https://doi.org/10.3389/fphar.2019.00918 . PMID: 31507416; PMCID: PMC6715768.
doi: 10.3389/fphar.2019.00918
pubmed: 31507416
pmcid: 6715768
Maggio MC, Ragusa SS, Corsello G. Early treatment of systemic juvenile idiopathic arthritis with Canakinumab and Complete Remission after 2 years of treatment suspension: Case Report of an adolescent girl. Clin Drug Investig. 2019;39(5):491–4. https://doi.org/10.1007/s40261-019-00766-9 . PMID: 30847869; PMCID: PMC6478625.
doi: 10.1007/s40261-019-00766-9
pubmed: 30847869
pmcid: 6478625
Vitale A, Caggiano V, Sfikakis PP, Dagna L, Lopalco G, Ragab G, La Torre F, Almaghlouth IA, Maggio MC, Sota J, Tufan A, Hinojosa-Azaola A, Iannone F, Loconte R, Laskari K, Direskeneli H, Ruscitti P, Morrone M, Mayrink Giardini HA, Panagiotopoulos A, Di Cola I, Martín-Nares E, Monti S, De Stefano L, Kardas RC, Duran R, Campochiaro C, Tomelleri A, Alabdulkareem AM, Gaggiano C, Tarsia M, Bartoloni E, Romeo M, Hussein MA, Laymouna AH, Parente de Brito Antonelli I, Dagostin MA, Fotis L, Bindoli S, Navarini L, Alibaz-Oner F, Sevik G, Frassi M, Ciccia F, Iacono D, Crisafulli F, Portincasa P, Jaber N, Kawakami-Campos PA, Wiesik-Szewczyk E, Iagnocco A, Simonini G, Sfriso P, Balistreri A, Giacomelli R, Conti G, Frediani B, Fabiani C, Cantarini L. Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease. Front Med (Lausanne). 2023;10:1256243. https://doi.org/10.3389/fmed.2023.1256243 . PMID: 38148914; PMCID: PMC10749954.
doi: 10.3389/fmed.2023.1256243
pubmed: 38148914
Maggio MC, Corsello G. FMF is not always fever: from clinical presentation to treat to target. Ital J Pediatr. 2020;46(1):7. https://doi.org/10.1186/s13052-019-0766-z . PMID: 31941537; PMCID: PMC6961393.
doi: 10.1186/s13052-019-0766-z
pubmed: 31941537
pmcid: 6961393
Maggio MC, Ceccherini I, Grossi A, Gattorno M, Corsello G. PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report. Ital J Pediatr. 2019;45(1):111. https://doi.org/10.1186/s13052-019-0705-z . PMID: 31443670; PMCID: PMC6708240.
doi: 10.1186/s13052-019-0705-z
pubmed: 31443670
pmcid: 6708240
Gaggiano C, Vitale A, Obici L, Merlini G, Soriano A, Viapiana O, Cattalini M, Maggio MC, Lopalco G, Montin D, Jaber MA, Dagna L, Manna R, Insalaco A, Piga M, La Torre F, Berlengiero V, Gelardi V, Ciarcia L, Emmi G, Ruscitti P, Caso F, Cimaz R, Hernández-Rodríguez J, Parronchi P, Sicignano LL, Verrecchia E, Iannone F, Sota J, Grosso S, Salvarani C, Frediani B, Giacomelli R, Mencarelli MA, Renieri A, Rigante D, Cantarini L. Clinical features at Onset and genetic characterization of Pediatric and adult patients with TNF-α receptor-Associated Periodic Syndrome (TRAPS): a Series of 80 cases from the AIDA Network. Mediators Inflamm. 2020;2020:8562485. https://doi.org/10.1155/2020/8562485 . PMID: 32831641; PMCID: PMC7428902.
doi: 10.1155/2020/8562485
pubmed: 32831641
pmcid: 7428902
Maggio MC, Cimaz R, Alaimo A, Comparato C, Di Lisi D, Corsello G. Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings. J Med Case Rep. 2019;13(1):104. https://doi.org/10.1186/s13256-019-2028-5 . PMID: 31014402; PMCID: PMC6480815.
doi: 10.1186/s13256-019-2028-5
pubmed: 31014402
pmcid: 6480815
Arantes Junior MAF, Conegundes AF, Branco Miranda BC, Radicchi Campos ASR, França Vieira AL, Faleiro MD, Campos MA, Kroon EG, Bentes AA. Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: systematic review and meta-analysis. Rev Med Virol. 2023;33(3):e2432. https://doi.org/10.1002/rmv.2432 . Epub 2023 Feb 18. PMID: 36807958.
doi: 10.1002/rmv.2432
pubmed: 36807958
Cascio A, Maggio MC, Cardella F, Zangara V, Accomando S, Costa A, Iaria C, Mansueto P, Giordano S. Coronary involvement in Mediterranean spotted fever. New Microbiol. 2011;34(4):421–4. Epub 2011 Oct 31. PMID: 22143818.
pubmed: 22143818
Maggio MC, Fabiano C, Corsello G. Kawasaki disease triggered by EBV virus in a child with familial Mediterranean Fever. Ital J Pediatr. 2019;45(1):129. https://doi.org/10.1186/s13052-019-0717-8 . PMID: 31627741; PMCID: PMC6798734.
doi: 10.1186/s13052-019-0717-8
pubmed: 31627741
pmcid: 6798734
Batu ED, Sener S, Ozomay Baykal G, Arslanoglu Aydin E, Özdel S, Gagro A, Esen E, Heshin-Bekenstein M, Akpınar Tekgöz N, Demirkan FG, Ozturk K, Vougiouka O, Sonmez HE, Maggio MC, Kaya Akca U, Jelusic M, Pac Kısaarslan A, Acar B, Aktay Ayaz N, Sözeri B, Özen S. Pediatric Rheumatology European Society (PReS) Vasculitis Working Party. The characteristics of patients with COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study. Arthritis Rheumatol. 2023;75(4):499–506. Epub 2023 Jan 23. PMID: 36457245; PMCID: PMC9877558.
doi: 10.1002/art.42411
pubmed: 36457245
Eichhorn C, Greulich S, Bucciarelli-Ducci C, Sznitman R, Kwong RY, Gräni C. Multiparametric Cardiovascular Magnetic Resonance Approach in Diagnosing, Monitoring, and prognostication of Myocarditis. JACC Cardiovasc Imaging. 2022;15(7):1325–38. Epub 2022 Jan 12. PMID: 35592889.
doi: 10.1016/j.jcmg.2021.11.017
pubmed: 35592889